What will be the future of Pcd pharma franchise companies after ban at 340 drug combinations in India?
Most of Pcd pharma companies are small and macro companies. They have only approximately 200 products in their price list. With coming of first 340 molecule list, an average of 10 to 15 products from price list has been banned. Some higher antibiotic combination drugs were main volume producer in invoicing. Approximately 15 percentage of …